Polish Version Fatigue Severity Scale

Sponsor
Jakub Antczak
Study ID
NCT06668649
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Testing with Questionnaires — DIAGNOSTIC_TEST
    Testing with following Questionnaires: pFSS, Polish-language version of Modified Fatigue Impact Scale, Visual Analogue Scale of Fatigue, EQ-5D-5L (EuroQol-5 dimension) questionnaire, Beck Depression Inventory II. In randomly selected 30 patients and 20 controls questionnaires will be administered twice with two weeks interval to assess the test-retest reliability.

Study Details

Fatigue is one of main symptoms in multiple sclerosis, amyotrophic lateral sclerosis and other diseases with profound effect on quality of life and professional and social functioning. Not infrequent it is misdiagnosed as sleepiness or other symptom. Fatigue severity scale is a time efficient and easy to apply instrument to assess the impact of fatigue on patient's life. The aim of this study is to validate the Polish-language version of the Fatigue Severity Scale.

Key Dates

First listed
Oct 31, 2024
Start date
Nov 4, 2024
Status verified
Nov 2024
Primary completion
Dec 31, 2026
Completion
Mar 31, 2027

Study Design

Enrollment
310 participants (estimated)

Arms

  • Arm: Patients
    Both sexes, aged 18 or older. The group will include 80 patients with multiple sclerosis, 80 patients with amyotrophic lateral sclerosis and 50 survivors of ischemic stroke
  • Arm: Control
    Both sexes, aged 18 or older. The group will include 100 healthy controls.

Primary Outcome Measure

Internal Consistency [ Time Frame: Through study completion, an average of 1 year ]

Central Contacts

Find similar trials

Nationwide
Multiple sclerosis trialsNeurology trialsBrain disorders trialsAutoimmune disease trials

Related Studies